NTRA Q2 2019 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q2 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$74M+17.9% YoY

Gross Profit

$31M41.1% margin

Operating Income

-$29M-38.5% margin

Net Income

-$32M-43.6% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+11.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$383M

Total Liabilities

$290M

Stockholders' Equity

$93M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74M	$63M	+17.9%
Gross Profit	$31M	$22M	+38.3%
Operating Income	-$29M	-$27M	-5.2%
Net Income	-$32M	-$34M	+4.2%

Revenue Segments

Product

$65M44%

Panorama Nipt

$36M25%

Hcs

$24M16%

Licensing And Other

$9M6%

Bgi Genomics Co Ltd

$5M3%

Other Genetic Tests

$4M3%

Other Licensing And Other

$2M2%

Constellation

$1M1%

Qiagen

$527,0000%

Geographic Segments

U

$62M84%

Other Geographic Areas

$7M9%

E M E A

$4M6%

Americas Excluding Us

$767,0001%